As pharmaceutical and biotechnology companies increasingly turn to IT to reduce costs and time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life sciences market.
This model will provide a forecast and analysis of IT spending in the pharma/biotech industries through 2014.
Key reasons to purchase this title
- Understand the opportunity size for technology spending in the global life sciences market
- Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies
- Segment the life sciences industry by spending opportunities
